XGene Regulatory Intelligence Platform
Search regulatory findings, guidance, expert analysis, and practical resources.
Connect enforcement signals to quality systems, services, expert commentary, and implementation resources.
ALCOA+ Data Completeness — The Deletion Problem FDA Finds First
In this articleSection 1 — What Completeness Requires: The Full Data Set Principle in FDA Enforcement PositionsSection 2 — How […]
View details →
FDA’s 2026 Quality Management Maturity Pilot: What It Means for Mid-Size Manufacturers
FDA's new voluntary quality maturity pilot could eventually influence inspection frequency. Here's how mid-size manufacturers should decide whether to participate now.
View details →Inside a GMP Facility Inspection: What Auditors Actually Look For
Our quality team breaks down the anatomy of a GMP facility inspection, from document requests to shop-floor walkthroughs, and shares […]
View details →Navigating FDA Pre-Submission Meetings: A Practical Guide
In this episode, we sit down with a former FDA reviewer to break down exactly what happens in a Pre-Submission […]
View details →Regulatory Strategy Advisory
End-to-end regulatory strategy support for pharmaceutical, biotech, and medical device teams — from early development planning through submission and post-approval […]
